Campari2 genomic interrogation of homeostatic calcium activity identifies TIM1 as a negative regulator of T cell function
Calcium signals regulate crucial cellular functions yet many genes coding for Ca<sup>2+</sup>handling proteins remain unknown as their identification relies on low-throughput single-cell approaches. Here we describe a method to measure Ca<sup>2+</sup> activity using CaMPARI2, flow cytometry and pooled genome interrogation. CAMPARI2 screen (CaMP-Screen) identified enhancers and inhibitors of homeostatic Ca<sup>2+</sup> activity, highlighting a predominant role for store-operated Ca<sup>2+</sup> entry (SOCE) and lipid signalling pathways. Genes reducing basal Ca<sup>2+</sup> activity were linked to Prader Willy syndrome, T cell dysfunction, and deafness. Silencing of HAVCR1 gene, coding for T cell transmembrane immunoglobulin and mucin (TIM1), enhanced Ca<sup>2+</sup> signals in T cells and promoted signaling under resting but not after TCR engagement. Our findings establish CaMP-Screen as an efficient detector of low-amplitude Ca<sup>2+</sup> signals and identify new genes associated to pathologies that regulate Ca<sup>2+</sup> homeostasis, reporting TIM1 as a negative regulator of Ca<sup>2+</sup> signals driving T cell function.
Authors
- Nicolas Demaurex (ORCID: https://orcid.org/0000-0002-9933-6772)
- Raphaël Néré (ORCID: https://orcid.org/0009-0005-9871-7898)
- Cyril Castelbou
- Sana Kouba (ORCID: https://orcid.org/0000-0003-4221-2952)
- Amado Carreras-Sureda
- Xin Zhang (ORCID: https://orcid.org/0000-0003-0047-3134)
Institutions
- University of Geneva (CH)
Publication Details
- Journal
- Cell Calcium
- Published
- 2025-05-17
- DOI
- https://doi.org/10.1016/j.ceca.2025.103036
- Primary Topic
- Signaling Pathways in Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Sir Jules Thorn Charitable Trust
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Novartis Institutes for BioMedical Research